Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules.

Baldwin DR, Gustafson J, Pickup L, Arteta C, Novotny P, Declerck J, Kadir T, Figueiras C, Sterba A, Exell A, Potesil V, Holland P, Spence H, Clubley A, O'Dowd E, Clark M, Ashford-Turner V, Callister ME, Gleeson FV.

Thorax. 2020 Apr;75(4):306-312. doi: 10.1136/thoraxjnl-2019-214104. Epub 2020 Mar 5.

2.

Preventative Agents: The Multiple Uses of Silver Nanoparticles in Dentistry.

Callister C, Callister M, Nolan M, Nolan R.

Compend Contin Educ Dent. 2020 Mar;41(3):143-147; quiz 148.

PMID:
32125166
3.

Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review.

Bradley SH, Abraham S, Callister ME, Grice A, Hamilton WT, Lopez RR, Shinkins B, Neal RD.

Br J Gen Pract. 2019 Nov 28;69(689):e827-e835. doi: 10.3399/bjgp19X706853. Print 2019 Dec.

PMID:
31636130
4.

Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.

Spiro SG, Shah PL, Rintoul RC, George J, Janes S, Callister M, Novelli M, Shaw P, Kocjan G, Griffiths C, Falzon M, Booton R, Magee N, Peake M, Dhillon P, Sridharan K, Nicholson AG, Padley S, Taylor MN, Ahmed A, Allen J, Ngai Y, Chinyanganya N, Ashford-Turner V, Lewis S, Oukrif D, Rabbitts P, Counsell N, Hackshaw A.

Eur Respir J. 2019 Oct 17;54(4). pii: 1900581. doi: 10.1183/13993003.00581-2019. Print 2019 Oct.

5.

Low-dose Computed Tomography Screening: The (Other) Lung Cancer Revolution.

Horst C, Callister MEJ, Janes SM.

Clin Oncol (R Coll Radiol). 2019 Oct;31(10):697-701. doi: 10.1016/j.clon.2019.07.022. Epub 2019 Aug 27. No abstract available.

PMID:
31471179
6.

Lung cancer.

Neal RD, Sun F, Emery JD, Callister ME.

BMJ. 2019 Jun 3;365:l1725. doi: 10.1136/bmj.l1725. No abstract available.

7.

The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening.

Gracie K, Kennedy MPT, Esterbrook G, Smith G, Blaxill P, Ameri AT, Rodger KIA, Robson JM, Paramasivam E, Naseer R, Smith P, Ellames DAB, Hawramy B, Callister MEJ.

Eur Respir J. 2019 Aug 8;54(2). pii: 1802221. doi: 10.1183/13993003.02221-2018. Print 2019 Aug. No abstract available.

PMID:
31097516
8.

Development and validation of clinical prediction models to risk stratify patients presenting with small pulmonary nodules: a research protocol.

Oke JL, Pickup LC, Declerck J, Callister ME, Baldwin D, Gustafson J, Peschl H, Ather S, Tsakok M, Exell A, Gleeson F.

Diagn Progn Res. 2018 Nov 29;2:22. doi: 10.1186/s41512-018-0044-3. eCollection 2018.

9.

Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.

Robbins HA, Callister M, Sasieni P, Quaife SL, Cheung LC, Brennan P, Katki HA, Berg CD, Baldwin D, Johansson M.

Lancet Respir Med. 2019 Aug;7(8):655-656. doi: 10.1016/S2213-2600(19)30136-5. Epub 2019 May 7. No abstract available. Erratum in: Lancet Respir Med. 2019 Jul;7(7):e22.

10.

Tweeting the Headache Meetings: Cross-Sectional Analysis of Twitter Activity Surrounding American Headache Society Conferences.

Callister MN, Robbins MS, Callister NR, Vargas BB.

Headache. 2019 Apr;59(4):518-531. doi: 10.1111/head.13500. Epub 2019 Mar 20.

PMID:
30891749
11.

Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis.

Spencer KL, Kennedy MPT, Lummis KL, Ellames DAB, Snee M, Brunelli A, Franks K, Callister MEJ.

Eur Respir J. 2019 Jun 20;53(6). pii: 1801568. doi: 10.1183/13993003.01568-2018. Print 2019 Jun.

12.

Minute ventilation-to-carbon dioxide slope is associated with postoperative survival after anatomical lung resection.

Miyazaki T, Callister MEJ, Franks K, Dinesh P, Nagayasu T, Brunelli A.

Lung Cancer. 2018 Nov;125:218-222. doi: 10.1016/j.lungcan.2018.10.003. Epub 2018 Oct 4.

PMID:
30429023
13.

Level of accuracy of diagnoses recorded in discharge summaries: A cohort study in three respiratory wards.

Tsopra R, Wyatt JC, Beirne P, Rodger K, Callister M, Ghosh D, Clifton IJ, Whitaker P, Peckham D.

J Eval Clin Pract. 2019 Feb;25(1):36-43. doi: 10.1111/jep.13020. Epub 2018 Aug 14.

14.

EORTC QLQ-C30 summary score reliably detects changes in QoL three months after anatomic lung resection for Non-Small Cell Lung Cancer (NSCLC).

Pompili C, Koller M, Velikova G, Franks K, Absolom K, Callister M, Robson J, Imperatori A, Brunelli A.

Lung Cancer. 2018 Sep;123:149-154. doi: 10.1016/j.lungcan.2018.07.021. Epub 2018 Jul 17.

15.

Palliation or Prolongation? The Impact of a Peer-Review Intervention on Shortening Radiotherapy Schedules for Bone Metastases.

Walker GV, Shirvani SM, Borghero Y, Callister MD, Chamberlain DD, Grade EJ, Khan MK, Kumar R, Richmond JG, Roberts TJ, Likhacheva AO.

J Oncol Pract. 2018 Aug;14(8):e513-e516. doi: 10.1200/JOP.18.00042. Epub 2018 Jul 30.

PMID:
30059272
16.

Lung cancer stage-shift following a symptom awareness campaign.

Kennedy MPT, Cheyne L, Darby M, Plant P, Milton R, Robson JM, Gill A, Malhotra P, Ashford-Turner V, Rodger K, Paramasivam E, Johnstone A, Bhartia B, Karthik S, Foster C, Lovatt V, Hewitt F, Cresswell L, Coupland VH, Lüchtenborg M, Jack RH, Moller H, Callister MEJ.

Thorax. 2018 Dec;73(12):1128-1136. doi: 10.1136/thoraxjnl-2018-211842. Epub 2018 Jun 27.

PMID:
29950525
17.

The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical care.

Tsopra R, Peckham D, Beirne P, Rodger K, Callister M, White H, Jais JP, Ghosh D, Whitaker P, Clifton IJ, Wyatt JC.

Int J Med Inform. 2018 Jul;115:35-42. doi: 10.1016/j.ijmedinf.2018.03.015. Epub 2018 Mar 27.

PMID:
29779718
18.

British Thoracic Society quality standards for the investigation and management of pulmonary nodules.

Baldwin D, Callister M, Akram A, Cane P, Draffan J, Franks K, Gleeson F, Graham R, Malhotra P, Pearson P, Subesinghe M, Waller D, Woolhouse I.

BMJ Open Respir Res. 2018 Apr 16;5(1):e000273. doi: 10.1136/bmjresp-2017-000273. eCollection 2018.

19.

Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.

Møller H, Coupland VH, Tataru D, Peake MD, Mellemgaard A, Round T, Baldwin DR, Callister MEJ, Jakobsen E, Vedsted P, Sullivan R, Spicer J.

Thorax. 2018 Jun;73(6):530-537. doi: 10.1136/thoraxjnl-2017-210710. Epub 2018 Mar 6.

20.

Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?

Jones CM, Brunelli A, Callister ME, Franks KN.

Curr Surg Rep. 2018;6(2):5. doi: 10.1007/s40137-018-0202-0. Epub 2018 Feb 8. Review.

21.

Low dose CT screening for lung cancer.

Baldwin DR, Ten Haaf K, Rawlinson J, Callister MEJ.

BMJ. 2017 Dec 28;359:j5742. doi: 10.1136/bmj.j5742. No abstract available.

PMID:
29284594
22.

European position statement on lung cancer screening.

Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, Baldwin DR, Callister ME, Becker N, Heuvelmans MA, Rzyman W, Infante MV, Pastorino U, Pedersen JH, Paci E, Duffy SW, de Koning H, Field JK.

Lancet Oncol. 2017 Dec;18(12):e754-e766. doi: 10.1016/S1470-2045(17)30861-6. Review.

PMID:
29208441
23.

Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC).

Pompili C, Franks KN, Brunelli A, Hussain YS, Holch P, Callister ME, Robson JM, Papagiannopoulos K, Velikova G.

J Thorac Dis. 2017 Aug;9(8):2703-2713. doi: 10.21037/jtd.2017.07.35.

24.

Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.

Mishra EK, Clive AO, Wills GH, Davies HE, Stanton AE, Al-Aloul M, Hart-Thomas A, Pepperell J, Evison M, Saba T, Harrison RN, Guhan A, Callister ME, Sathyamurthy R, Rehal S, Corcoran JP, Hallifax R, Psallidas I, Russell N, Shaw R, Dobson M, Wrightson JM, West A, Lee YCG, Nunn AJ, Miller RF, Maskell NA, Rahman NM.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):502-508. doi: 10.1164/rccm.201704-0809OC. Erratum in: Am J Respir Crit Care Med. 2018 Apr 15;197(8):1092-1093.

PMID:
28926296
25.

Physician Assessment of Pretest Probability of Malignancy and Adherence to Guidelines for Pulmonary Nodule Evaluation.

Baldwin DR, Callister MEJ.

Chest. 2017 Aug;152(2):447-448. doi: 10.1016/j.chest.2017.03.045. No abstract available.

PMID:
28797389
26.

Defining the path: lung cancer CT screening in Europe.

Callister ME, Janes SM.

Thorax. 2017 Sep;72(9):778-779. doi: 10.1136/thoraxjnl-2017-210268. Epub 2017 Jul 19. No abstract available.

PMID:
28724640
27.

Secondary-care costs associated with lung cancer diagnosed at emergency hospitalisation in the United Kingdom.

Kennedy MPT, Hall PS, Callister MEJ.

Thorax. 2017 Oct;72(10):950-952. doi: 10.1136/thoraxjnl-2016-209616. Epub 2017 Jan 30.

PMID:
28137919
28.

Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer.

Pompili C, Velikova G, White J, Callister M, Robson J, Dixon S, Franks K, Brunelli A.

Eur J Cardiothorac Surg. 2017 Mar 1;51(3):526-531. doi: 10.1093/ejcts/ezw363.

29.

Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study.

Qureshi NR, Rintoul RC, Miles KA, George S, Harris S, Madden J, Cozens K, Little LA, Eichhorst K, Jones J, Moate P, McClement C, Pike L, Sinclair D, Wong WL, Shekhdar J, Eaton R, Shah A, Brindle L, Peebles C, Banerjee A, Dizdarevic S, Han S, Poon FW, Groves AM, Kurban L, Frew AJ, Callister ME, Crosbie P, Gleeson FV, Karunasaagarar K, Kankam O, Gilbert FJ.

BMJ Open Respir Res. 2016 Oct 14;3(1):e000156. eCollection 2016.

30.

How should performance in EBUS mediastinal staging in lung cancer be measured?

Evison M, Crosbie P, Navani N, Callister M, Rintoul RC, Baldwin D, Booton R.

Br J Cancer. 2016 Oct 11;115(8):e9. doi: 10.1038/bjc.2016.253. Epub 2016 Aug 23. No abstract available.

31.

What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.

Baldwin DR, Callister ME.

Clin Oncol (R Coll Radiol). 2016 Nov;28(11):672-681. doi: 10.1016/j.clon.2016.08.001. Epub 2016 Aug 17. Review.

PMID:
27544425
32.

Factors affecting hospital costs in lung cancer patients in the United Kingdom.

Kennedy MP, Hall PS, Callister ME.

Lung Cancer. 2016 Jul;97:8-14. doi: 10.1016/j.lungcan.2016.04.009. Epub 2016 Apr 14.

PMID:
27237021
33.

Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules.

Graham RN, Baldwin DR, Callister ME, Gleeson FV.

Br J Radiol. 2016;89(1059):20150776. doi: 10.1259/bjr.20150776. Epub 2016 Jan 19.

34.

How should pulmonary nodules be optimally investigated and managed?

Callister ME, Baldwin DR.

Lung Cancer. 2016 Jan;91:48-55. doi: 10.1016/j.lungcan.2015.10.018. Epub 2015 Oct 27. Review.

PMID:
26711934
35.

Pulmonary nodules again? The 2015 British Thoracic Society guidelines on the investigation and management of pulmonary nodules.

Baldwin DR, Callister ME, Graham R, Gleeson F; members of the Guideline Development Group.

Clin Radiol. 2016 Jan;71(1):18-22. doi: 10.1016/j.crad.2015.10.017. Epub 2015 Nov 20. No abstract available.

PMID:
26607915
36.

Authors' response--Risk of malignancy in pulmonary nodules: a validation study of four prediction models.

Al-Ameri A, Malhotra P, Thygesen H, Plant PK, Vaidyanathan S, Karthik S, Scarsbrook A, Callister ME.

Lung Cancer. 2015 Oct;90(1):119-20. doi: 10.1016/j.lungcan.2015.07.013. Epub 2015 Jul 31. No abstract available.

PMID:
26271548
37.

The British Thoracic Society guidelines on the investigation and management of pulmonary nodules.

Baldwin DR, Callister ME; Guideline Development Group.

Thorax. 2015 Aug;70(8):794-8. doi: 10.1136/thoraxjnl-2015-207221. Epub 2015 Jul 1. Review.

PMID:
26135833
38.

British Thoracic Society guidelines for the investigation and management of pulmonary nodules.

Callister ME, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, Franks K, Gleeson F, Graham R, Malhotra P, Prokop M, Rodger K, Subesinghe M, Waller D, Woolhouse I; British Thoracic Society Pulmonary Nodule Guideline Development Group; British Thoracic Society Standards of Care Committee.

Thorax. 2015 Aug;70 Suppl 2:ii1-ii54. doi: 10.1136/thoraxjnl-2015-207168. No abstract available. Erratum in: Thorax. 2015 Dec;70(12):1188.

PMID:
26082159
39.

Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer.

Hinde S, McKenna C, Whyte S, Peake MD, Callister ME, Rogers T, Sculpher M.

Br J Cancer. 2015 Jun 30;113(1):135-41. doi: 10.1038/bjc.2015.167. Epub 2015 May 26.

40.
41.

Risk of malignancy in pulmonary nodules: A validation study of four prediction models.

Al-Ameri A, Malhotra P, Thygesen H, Plant PK, Vaidyanathan S, Karthik S, Scarsbrook A, Callister ME.

Lung Cancer. 2015 Jul;89(1):27-30. doi: 10.1016/j.lungcan.2015.03.018. Epub 2015 Mar 28.

PMID:
25864782
42.

Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.

Robson JM, Vaidyanathan S, Cheyne L, Snee M, Franks K, Callister ME.

Clin Lung Cancer. 2014 Nov;15(6):466-9. doi: 10.1016/j.cllc.2014.07.006. Epub 2014 Aug 15.

PMID:
25220208
43.

Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer.

Ashman JB, Moss AA, Rule WG, Callister MG, Reddy KS, Mulligan DC, Collins JM, De Petris G, Gunderson LL, Borad M.

J Gastrointest Oncol. 2013 Dec;4(4):352-60. doi: 10.3978/j.issn.2078-6891.2013.006.

44.

Social deprivation does not affect lung cancer stage at presentation or disease outcome.

Cheyne L, Taylor A, Milton R, Fear J, Callister ME.

Lung Cancer. 2013 Aug;81(2):247-51. doi: 10.1016/j.lungcan.2013.03.012. Epub 2013 Apr 6.

PMID:
23570796
45.

In reply to Vassiliou and Kountourakis.

Callister MD.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):570-1. doi: 10.1016/j.ijrobp.2012.08.034. No abstract available.

PMID:
22999267
46.

Clinical management of older people with non-small cell lung cancer in England.

Beckett P, Callister M, Tata LJ, Harrison R, Peake MD, Stanley R, Woolhouse I, Slade M, Hubbard RB.

Thorax. 2012 Sep;67(9):836-9. doi: 10.1136/thoraxjnl-2011-200994. Epub 2012 Jul 6.

PMID:
22771514
47.

Backbiting and bloodshed in books: short-term effects of reading physical and relational aggression in literature.

Coyne SM, Ridge R, Stevens M, Callister M, Stockdale L.

Br J Soc Psychol. 2012 Mar;51(1):188-96. doi: 10.1111/j.2044-8309.2011.02053.x. Epub 2011 Sep 1.

PMID:
21883301
48.

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities.

Curtis KK, Ashman JB, Beauchamp CP, Schwartz AJ, Callister MD, Dueck AC, Gunderson LL, Fitch TR.

Radiat Oncol. 2011 Aug 9;6:91. doi: 10.1186/1748-717X-6-91.

49.

A content analysis of the prevalence and portrayal of sexual activity in adolescent literature.

Callister M, Coyne SM, Stern LA, Stockdale L, Miller MJ, Wells BM.

J Sex Res. 2012;49(5):477-86. doi: 10.1080/00224499.2011.572306. Epub 2011 Jun 9.

PMID:
21660836
50.

Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.

Samuelian JM, Callister MD, Ashman JB, Young-Fadok TM, Borad MJ, Gunderson LL.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1981-7. doi: 10.1016/j.ijrobp.2011.01.051. Epub 2011 Apr 7.

PMID:
21477938

Supplemental Content

Loading ...
Support Center